Premium
Vitamin D status is linked with plasma glutathione and cysteine thiol/disulfide redox status in adults (260.4)
Author(s) -
Alvarez Jessica,
Chowdhury Ritam,
Jones Dean,
Martin Greg,
Brigham Kenneth,
Bigo Jose,
Ziegler Thomas,
Tangpricha Vin
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.260.4
Subject(s) - glutathione , glutathione disulfide , cysteine , cystine , thiol , redox , chemistry , inflammation , medicine , vitamin c , pathophysiology , endocrinology , oxidative stress , vitamin d and neurology , biochemistry , enzyme , organic chemistry
Objective: Redox status and inflammation are important in the pathophysiology of numerous chronic diseases. Epidemiological studies have linked vitamin D nutriture to a number of chronic diseases. We examined the relationships between serum 25‐hydroxyvitamin D (25(OH)D) concentrations and circulating biomarkers of redox and inflammation. Methods: We studied a community‐based cohort of working adults in Atlanta, GA (N=693). Plasma thiol/disulfide redox status was determined by HPLC [glutathione (GSH), glutathione disulfide (GSSG), cysteine (Cys), cystine (CySS), and their calculated redox potentials (Eh), calculated by the Nernst equation]. Pro‐inflammatory biomarkers included IL‐6, IL‐8, TNF‐α, and C‐reactive protein. Relationships were assessed by multiple linear regression. Results: Serum 25(OH)D levels were positively associated with plasma GSH levels, a more reducing GSH/GSSG EhCys, and inversely with Cys levels (P<0.001). These associations were not influenced by subject age, gender, race, % body fat, and cardiovascular risk factors (P<0.02). Serum 25(OH)D was not independently associated with any inflammatory marker. Conclusion: Serum 25(OH)D levels were independently associated with major plasma thiol/disulfide redox systems, suggesting that vitamin D status may be involved in redox‐mediated pathophysiology. Grant Funding Source : Supported by NIH (T32DK007298, UL1TR000454, K23AR054334, and K24RR023356).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom